Marc Carrier
Ottawa Hospital · Ottawa Hospital Research Institute · Ottawa Hospital Research Institute / Division of Hematology- The Ottawa Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Carrier as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06894576 · Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated ThrombosisOttawa Hospital Research Institute · recruiting · Cancer-associated Thrombosis · principal investigator
- Ph2/Ph3NCT06662253 · Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized TrialAlexandre Tran · unknown · Venous Thromboembolism (VTE), Trauma Related Injuries · principal investigator
- Ph3NCT06440694 · Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)Ottawa Hospital Research Institute · recruiting · Venous Thromboembolism · principal investigator
- Ph4NCT05255003 · STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisTzu-Fei Wang · recruiting · Cancer-associated Thrombosis, Thrombocytopenia · principal investigator
- Ph3NCT05029063 · Primary Thromboprophylaxis in Patients With Malignancy and Central Venous CathetersOttawa Hospital Research Institute · recruiting · Venous Thromboembolism, Cancer · principal investigator
- Ph2NCT03297359 · WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous ThromboembolismOttawa Hospital Research Institute · terminated · Cancer, Venous Thromboembolism, Obesity · principal investigator
- Ph2NCT02048865 · Apixaban for the Prevention of Venous Thromboembolism in Cancer PatientsOttawa Hospital Research Institute · completed · Venous Thromboembolism, Cancer · principal investigator
- Ph3NCT01455831 · Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerOttawa Hospital Research Institute · completed · Adenocarcinoma of the Colon · principal investigator
- N/ANCT00967148 · Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon CancerOttawa Hospital Research Institute · completed · Deep Vein Thrombosis, Pulmonary Embolism, Cancer · principal investigator
- N/ANCT00773448 · Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismOttawa Hospital Research Institute · completed · Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism · principal investigator
- Ph3NCT00421538 · Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)University Hospital, Geneva · completed · Distal (Calf) Deep-vein Thrombosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:27 UTC. The ranking covers the 200 most relevant of 114 PubMed records, and a shared surname and initials can bring in a namesake. All 114 on PubMed
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.N Engl J Med · 20181,214 citationsRCR 55.6
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.N Engl J Med · 2021788 citationsRCR 47.4
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.N Engl J Med · 2021753 citationsRCR 43.8
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.N Engl J Med · 2019678 citationsRCR 31.6
- 678 citationsRCR 30.5
- Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.N Engl J Med · 2018354 citationsRCR 19.1
- 281 citationsRCR 16.3
- Screening for Occult Cancer in Unprovoked Venous Thromboembolism.N Engl J Med · 2015227 citationsRCR 8.7
- Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.Ann Intern Med · 2013189 citationsRCR 7.5
- Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.PLoS Pathog · 2013186 citationsRCR 5.8